Our latest paper in collaboration with Pfizer on the role of OCT2/MATE in creatinine clearance is accepted in JPET.
Chief Commercial Officer
PhD in Biochemistry from University of Manchester.
Over 20 years of experience working in the life science and drug discovery industry, including various commercial roles at PerkinElmer, Discoverx, Qiagen and Axol Bioscience.
Working with customers on: capital equipment – liquid handling automation, robotics, detection instruments (plate readers, nuclear counters); consumables (cell lines, iPSCs, kits, reagents, disposables); service projects (technical solutions for various types of application).
Experience in Europe and North America.
Favourite Quotation: “Take nothing on its looks; take everything on evidence. There’s no better rule.” Charles Dickens in the exchange between Mr Jaggers and Pip in Great Expectations.